Stem cell transplantation into the intraventricular space via an Ommaya reservoir in a patient with amyotrophic lateral sclerosis

Journal of Neurosurgical Sciences

Volumn 56, Issue 3, 2012, Pages 261-263

  Baek, W ^a   Kim, Y S ^a   Koh, S H ^a   Lim, S W ^a   Kim, H Y ^a   Yi, H J ^b   Kim, H S ^a  

^a Hanyang University College of Medicine   (South Korea)

^b Hanyang University College of Medicine   (South Korea)

Author keywords

Amyotrophic lateral sclerosis; Injections, intraventricular; Stem cell transplantation

Indexed keywords

RILUZOLE;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW; CASE REPORT; CELL THERAPY; COMPUTER ASSISTED TOMOGRAPHY; ELECTROPHYSIOLOGY; HUMAN; MALE; MOTOR DYSFUNCTION; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OMMAYA RESERVOIR; PATIENT SAFETY; STEM CELL TRANSPLANTATION; CELL CULTURE; CYTOLOGY; INDWELLING CATHETER; INFUSION PUMP; INSTRUMENTATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; METHODOLOGY; MIDDLE AGED; TREATMENT OUTCOME;

AMYOTROPHIC LATERAL SCLEROSIS; CATHETERS, INDWELLING; CELLS, CULTURED; HUMANS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, INTRAVENTRICULAR; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84868255568     PISSN: 03905616     EISSN: 18271855     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Mazzini L, Ferrero I, Luparello V, Rustichelli D, Gunetti M, Mareschi K et al. Mesenchymalstem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial. Exp Neurol 2010;223:229-37.
2. Kim HY, Paek JY, Park HK, Choi MR, Yoon HS, Kim KS et al. Efficacy and safety of autologous bone marrow-derived mesenchymal stem cell treatment in patients with amyotrophic lateral sclerosis J Korean Neurol Assoc 2009;27.
3. Kim H, Kim HY, Choi MR, Hwang S, Nam KH, Kim HC et al. Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice. Neurosci Lett 2010;468:190-4.
4. Al-Anazi A, Bernstein M. Modified stereotactic insertion of the Ommaya reservoir. Technical note. J Neurosurg 2000;92:1050-2. (Pubitemid 30346528)
5. Shapiro WR, Young DF, Mehta BM. Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. N Engl J Med 1975;293:161-6.
6. Sundaresan N, Suite ND. Optimal use of the Ommaya reservoir in clinical oncology. Oncology (Williston Park) 1989;3:15-22; discussion 23.
7. Ommaya AK. Implantable devices for chronic access and drug delivery to the central nervous system. Cancer Drug Deliv 1984;1:169-79. (Pubitemid 15187895)
8. Balis FM, Blaney SM, McCully CL, Bacher JD, Murphy RF, Poplack DG. Methotrexate distribution within the subarachnoid space after intraventricular and intravenous administration. Cancer Chemother Pharmacol 2000;45:259-64. (Pubitemid 30099774)
9. Haaxma-Reiche H, Piers A, Beekhuis H. Normal cerebrospinal fluid dynamics. A study with intraventricular injection of 111In-DTPA in leukemia and lymphoma without meningeal involvement. Arch Neurol 1989;46:997-9. (Pubitemid 19227224)
10. Blasberg RG, Patlak CS, Shapiro WR. Distribution of methotrexate in the cerebrospinal fluid and brain after intraventricular administration. Cancer Treat Rep 1977;61:633-41. (Pubitemid 8156473)